[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?]

CONCLUSION: A neoadjuvant treatment is clearly recommended for locally advanced esophageal cancer. Currently, chemoradiotherapy according to the CROSS protocol is preferred for squamous cell carcinoma. For adenocarcinoma both chemotherapy according to the FLOT protocol as well as chemoradiotherapy in a neoadjuvant treatment concept lead to an improvement in the prognosis. PMID: 32140748 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32140748?dopt=Abstract

Source: Der Chirurg - March 4, 2020 Category: Surgery Authors: Babic B, Fuchs HF, Bruns CJ Tags: Chirurg Source Type: research